Linda Lee | |
|---|---|
| Member of the
New York City Council from the 23rd district | |
| Assumed office January 1, 2022 | |
| Preceded by | Barry Grodenchik |
| Personal details | |
| Born | July 3, 1979 |
| Political party | Democratic |
| Education | Columbia University ( BA, MSW) |
| Website |
Official website Campaign website |
Linda Lee (born July 3, 1979) is an American politician from New York City who is the city councilmember of New York City's 23rd City Council district, representing the Democratic Party. [1]
Lee grew up in Oakland Gardens, Queens. She received her B.A. from Barnard College of Columbia University and her Master's of Social Work from Columbia. [2] Before running in the council elections aged 42, she had never previously sought office. [3] She campaigned for election on a platform of increasing services for senior citizens, improving the accountability of police to citizens, and workforce training to help recover the economy in the aftermath of the COVID-19 pandemic. [4]
After winning the November 2021 general election, she became the first Asian American woman to represent the district, along with a wave of previously unrepresented minorities on the City Council. [1] She succeeded fellow Democrat Barry Grodenchik; her term is intended to run for two years instead of the usual four because of planned redistricting. [5]
References
- ^ a b Gold, Michael; Zraick, Karen (November 4, 2021). "N.Y. City Council Sees Historic Changes, and Republicans Gain Ground". The New York Times. Retrieved November 16, 2021.
- ^ "Biography". Linda Lee. Retrieved 2022-02-10.
- ^ Coltin, Jeff (November 4, 2021). "A Q&A with New York City Council Member-elect Linda Lee". City and State NY. Retrieved 15 November 2021.
- ^ Wang, Claire (November 3, 2021). "NYC Council has 5 new Asian Americans, a record that mirrors city more accurately". NBC News. Retrieved November 15, 2021.
- ^ Levy, Kayla (November 3, 2021). "Linda Lee Makes History, Named Bayside District 23 Council Winner". Bayside-Douglaston, NY Patch. Retrieved February 11, 2023.
